Application of decision-analytic models in personalized medicine for CML treatment decisions made by payers, providers, and patients

J Manag Care Pharm. 2012 Jul-Aug;18(6):457-63. doi: 10.18553/jmcp.2012.18.6.457.

Authors

Kim R Saverno¹, Ursula Rochau, David D Stenehjem, Kimberly Morley, Uwe Siebert, Diana I Brixner

Affiliation

¹ Department of Public Health and Health Technology Assessment, Institute of Public Health, Medical Decision Making and Health Technology Assessment, UMIT, University for Health Sciences, Medical Informatics, and Technology, Hall in Tirol, Austria.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Decision Making
Decision Support Techniques*
Health Personnel*
Humans
Insurance, Health, Reimbursement*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / economics
Precision Medicine / economics
Precision Medicine / methods*